135 results on '"Glogowski, Emily"'
Search Results
2. Great expectations: patients’ preferences for clinically significant results from genomic sequencing
3. “I don’t need any more unknowns hanging over my head”: Views of patients with cancer on variants of uncertain significance and low/moderate risk results from genomic sequencing
4. How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey
5. Patient and public preferences for being recontacted with updated genomic results: a mixed methods study
6. Development of patient “profiles” to tailor counseling for incidental genomic sequencing results
7. “I don’t need any more unknowns hanging over my head”: Cancer patients’ views on variants of uncertain significance and low/moderate risk results from genomic sequencing
8. P555: Clinical utility returning of all types of medically relevant genomic sequencing findings: An observational study
9. P538: Curious but cautious: Patients’ preferences for all types of clinically actionable genomic incidental results
10. P523: Returning all clinically relevant findings from genomic sequencing: Preliminary results from the incidental genomics RCT
11. A model for the return and referral of all clinically significant secondary findings of genomic sequencing
12. “I Don’t Want to Be an Ostrich”: Managing Mothers’ Uncertainty during BRCA1/2 Genetic Counseling
13. Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support Group
14. Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery
15. eP502: How will returning variants of uncertain significance impact healthcare use? A cross-sectional survey
16. eP299: Genetics adviser: The development and usability testing of a new patient-centered digital health application to support clinical genomic testing
17. Assessment of individuals with BRCA1 and BRCA2 large rearrangements in high-risk breast and ovarian cancer families
18. Prospective Immunohistochemical Analysis of Primary Colorectal Cancers for Loss of Mismatch Repair Protein Expression
19. The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care
20. Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome
21. UTILITY OF PROSPECTIVE PATHOLOGIC EVALUATION TO INFORM CLINICAL GENETIC TESTING FOR HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA: MP36-06
22. OUTCOME OF GENETIC EVALUATION OF KIDNEY CANCER PATIENTS REFERRED FOR SUSPECTED HEREDITARY CANCER SYNDROMES: PD10-05
23. PARC report: a health-systems focus on reimbursement and patient access to pharmacogenomics testing
24. PARC report: a perspective on the state of clinical pharmacogenomics testing
25. Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial
26. Increased frequency of disease-causing MYH mutations in colon cancer families
27. A636P is associated with early-onset colon cancer in Ashkenazi Jews
28. High glucose alters the response of mesangial cell protein kinase C isoforms to endothelin-1
29. Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial
30. The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results
31. Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial
32. Counseling and Testing for Inherited Predisposition to Cancer
33. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma
34. Quality of life drives patients’ preferences for secondary findings from genomic sequencing
35. “I don’t need any more unknowns hanging over my head”: Views of patients with cancer on variants of uncertain significance and low/moderate risk results from genomic sequencing
36. A636P testing in Ashkenazi Jews
37. Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support Group
38. “I Don’t Want to Be an Ostrich”: Managing Mothers’ Uncertainty during BRCA1/2 Genetic Counseling
39. Feasibility and long-term utility of a psychosocial support group for patients with Lynch syndrome.
40. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes
41. Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon General’s My Family Health Portrait
42. MP36-06 UTILITY OF PROSPECTIVE PATHOLOGIC EVALUATION TO INFORM CLINICAL GENETIC TESTING FOR HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA
43. PD10-05 OUTCOME OF GENETIC EVALUATION OF KIDNEY CANCER PATIENTS REFERRED FOR SUSPECTED HEREDITARY CANCER SYNDROMES
44. Talking About Familial Breast Cancer Risk
45. Needs assessment and utilization of an educational workshop and support group for Lynch syndrome patients.
46. Sources of Uncertainty About Daughters’ Breast Cancer Risk that Emerge During Genetic Counseling Consultations
47. Single-amplicon MSH2 A636P Mutation Testing in Ashkenazi Jewish Patients With Colorectal Cancer
48. Pleomorphic Characteristics of a Germ-LineKITMutation in a Large Kindred with Gastrointestinal Stromal Tumors, Hyperpigmentation, and Dysphagia
49. MSH6 germline mutations are rare in colorectal cancer families
50. Practicum in assessing family history of cancer to inform colorectal cancer screening
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.